CIPRODEX is a Auricular (otic) Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Ciprofloxacin Hydrochloride; Dexamethasone.
| Product ID | 0065-8533_7f9e10f3-fa47-46ad-a689-1190f09714d2 | 
| NDC | 0065-8533 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | CIPRODEX | 
| Generic Name | Ciprofloxacin And Dexamethasone | 
| Dosage Form | Suspension/ Drops | 
| Route of Administration | AURICULAR (OTIC) | 
| Marketing Start Date | 2003-08-04 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021537 | 
| Labeler Name | Alcon Laboratories, Inc. | 
| Substance Name | CIPROFLOXACIN HYDROCHLORIDE; DEXAMETHASONE | 
| Active Ingredient Strength | 3 mg/mL; mg/mL | 
| Pharm Classes | Quinolone Antimicrobial [EPC],Quinolones [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2003-08-04 | 
| Marketing End Date | 2021-11-30 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021537 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2003-08-04 | 
| Marketing Category | NDA | 
| Application Number | NDA021537 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2003-08-04 | 
| Marketing Category | NDA | 
| Application Number | NDA021537 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2003-08-04 | 
| Marketing End Date | 2011-07-11 | 
| Marketing Category | NDA | 
| Application Number | NDA021537 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2003-08-04 | 
| Marketing Category | NDA | 
| Application Number | NDA021537 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-05-19 | 
| Ingredient | Strength | 
|---|---|
| CIPROFLOXACIN HYDROCHLORIDE | 3 mg/mL | 
| SPL SET ID: | 0ed518de-4ae1-43d1-84ff-26872d9e6a0f | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0065-8533 | CIPRODEX | ciprofloxacin and dexamethasone | 
| 0078-0799 | CIPRODEX | ciprofloxacin and dexamethasone | 
| 21695-969 | CIPRODEX | ciprofloxacin and dexamethasone | 
| 68071-1629 | CIPRODEX | ciprofloxacin and dexamethasone | 
| 71205-309 | CIPRODEX | ciprofloxacin and dexamethasone | 
| 0781-6186 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone | 
| 16714-628 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone | 
| 43598-326 | Ciprofloxacin and Dexamethasone | Ciprofloxacin and Dexamethasone | 
| 62756-427 | Ciprofloxacin and dexamethasone | Ciprofloxacin and dexamethasone | 
| 63629-8797 | Ciprofloxacin and Dexamethasone | ciprofloxacin and dexamethasone | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() CIPRODEX  75935885  2513415 Live/Registered  | 
        Bayer Aktiengesellschaft  2000-03-06  |